Kim is a UC Davis Health medical oncologist and associate professor of internal medicine who specializes in treating gastrointestinal malignancies including pancreatic, liver, bile duct, esophageal, stomach, and colorectal cancer. He has conducted extensive clinical trials and was a recipient of the National Cancer Institute Cancer Clinical Team Leadership Award in 2015.

Kim and Edwards
Edward Kim (photo taken prior to COVID-19 social distancing and masking guidelines).

Kim reports to Karen Kelly, associate director for clinical research, who previously held the post of OCR medical director.

“As our new medical director of the Office of Clinical Research, Dr. Kim will lead the cancer center into the next era of oncology research, ensuring our innovative clinical investigations will meet federal, state and local requirements while promoting a collaborative research culture,” UC Davis Comprehensive Cancer Center Director Primo “Lucky” Lara Jr., said.

Kim has a particular interest in novel treatments for pancreatic cancer and previously served as chair of the UC Davis Pancreatic Cancer Research Incubator as well as chair of the Data and Safety Monitoring Committee (DSMC) which provides impartial oversight of investigator-initiated cancer trials.